At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive, and solutions are personal. Johnson & Johnson has made significant contributions to surgery for more than 100 years, from creating the first sutures, to revolutionizing surgery with minimally invasive procedures. Our surgical technologies and solutions include sutures, staplers, energy devices, trocars and hemostats along with interventional ablation, robotics, and digital solutions.

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.

We are a global leader in healthcare technology, committed to solving the world’s most challenging health problems. Our mission — to alleviate pain, restore health, and extend life — unites more than 95,000 passionate professionals worldwide. Driven by curiosity, expertise, and compassion, we deliver innovative solutions that transform lives every second of every day.

Beyond technology, we focus on insight-driven care, patient-first experiences, and better outcomes for all. Diversity fuels our innovation, and our relentless pursuit of progress ensures smarter, more accessible, and more human healthcare. Expect more from us as we continue to push boundaries and create meaningful impact across the globe.

osteobionix is an innovative medical technology company specializing in patient-specific solutions for orthopedic, trauma, spine, craniomaxillofacial (CMF) and thoracic surgery. Founded in 2018 as a spin-o of the Technology Institute of the Canary Islands, the company builds on more than a decade of applied research in 3D-printed porous titanium sca olds and customized implant design. Its scientific and engineering team has been developing, manufacturing and clinically validating personalized implants since 2010.

To date, osteobionix has designed, produced and successfully delivered more than 800 patient-specific implants, collaborating with leading surgeons and hospitals across 15 international markets. The company brings together advanced biomedical engineering, computational design, digital surgical planning and high-precision additive manufacturing to address reconstruction needs that cannot be solved with standard implants.

osteobionix is a recognized leader in thoracic surgery, with approximately 200 personalized chest wall reconstruction implants completed. In Spain, its patient-specific thoracic solutions have become the national gold standard for large chest wall reconstruction, supported by multiple peer-reviewed scientific publications demonstrating their safety, performance and clinical e icacy. These implants have enabled transformative outcomes for patients with oncologic resections and other complex conditions, contributing to improved respiratory function, stability and quality of life.

Driven by a mission to engineer bone behavior through biomimetic and regenerative design, osteobionix is shaping the future of reconstructive surgery with solutions that enhance surgical precision, reduce complications and expand clinical possibilities. Through continuous R&D, strong clinical partnerships and global market engagement, the company is advancing the next generation of personalized implants for patients worldwide.

Applied Medical designs, develops and manufactures innovative products that enable advanced surgical procedures and optimize patient outcomes. As a global medical device company, Applied Medical is equally committed to improving the affordability and accessibility of high-quality healthcare. We also further minimally invasive surgery by offering sophisticated training, including workshops, symposia and our simulation-based programs.